Who is sponsoring NCT06689592?

NCT06689592 is sponsored by University of Regensburg.

What drugs are being tested in NCT06689592?

Interventions in NCT06689592: Transcranial Magnetic Stimulation.

What condition does NCT06689592 study?

NCT06689592 studies Depression.

Is NCT06689592 still recruiting?

NCT06689592 is currently completed. Last updated 15 April 2025.

Last reviewed 2025-04-15 · How we verify

NCT06689592: MTMS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mobile Transcranial Magnetic Stimulation

Completed NA Last updated 15 April 2025

What this trial tests

NA trial testing Transcranial Magnetic Stimulation in Depression in 5 participants. Completed in 31 March 2025.

Timeline

15 August 2024

Primary endpoint
28 February 2025

31 March 2025

Quick facts

Lead sponsor	University of Regensburg
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	5
Start date	15 August 2024
Primary completion	28 February 2025
Estimated completion	31 March 2025
Sites	1 location across Germany

Drugs / interventions tested

Transcranial Magnetic Stimulation — full drug profile →

Conditions studied

Depression — all drugs for Depression →

Sponsor

University of Regensburg

Who can join

Adults 18 to 80, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

For this study 5 patients will be treated with transcranial magnetic stimulation in their residence (home, nursing home).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility of home-based accelerated intermittent theta-burst stimulation (aiTBS) for depression: a case series.
Kerkel K, Reissmann A, Langguth B, Osnabruegge M, et al · · 2026 · PMID 41908122 · DOI 10.3389/fpsyt.2026.1731673

Verify or expand the search:

Other trials of Transcranial Magnetic Stimulation

Trials testing the same drug.

NCT07526285 — Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) for Treatment of Post-Traumatic Stress Disorder (PTSD) · NA · not yet recruiting
NCT07050862 — rTMS for Tobacco Use in Veterans · NA · not yet recruiting
NCT07145866 — Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study) · Phase 4 · not yet recruiting
NCT07516028 — Brain Connectivity and Corticospinal Excitability in Response to Moderate Hypoxia · NA · not yet recruiting
NCT07389694 — Using Transcranial Magnetic Stimulation to Treat Stuttering · NA · recruiting

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other University of Regensburg trials

Trials by the same sponsor.

NCT07444242 — Accelerated Treatment of Depressive Patients With tDCS · NA · not yet recruiting
NCT06766214 — Attexis and tDCS for the Treatment of ADHD · NA · completed
NCT06520865 — TIDE Project: Biomarker Discovery for Chronic Tinnitus Diagnosis · completed
NCT06212895 — Expectations of Patients Regarding Exercise in an Outpatient Clinic · unknown
NCT05791812 — Application of Direct Current Transcranial stImulation, Remotely superVised in Chronic fATiguE · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06689592 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Regensburg
Last refreshed: 15 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06689592.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing